PharMerica Corporation  

(Public, NYSE:PMC)   Watch this stock  
Find more results for PMC
26.95
-0.05 (-0.19%)
Apr 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 26.73 - 27.20
52 week 11.84 - 28.58
Open 27.20
Vol / Avg. 290,151.00/287,620.00
Mkt cap 796.03M
P/E 43.25
Div/yield     -
EPS 0.62
Shares 29.54M
Beta 1.10
Inst. own 98%
Jun 17, 2014
PharMerica Corporation 2014 Annual Shareholder Meeting Add to calendar
May 1, 2014
Q1 2014 PharMerica Corporation Earnings Conference Call - 10:00AM EDT - Add to calendar
May 1, 2014
Q1 2014 PharMerica Corporation Earnings Release - 9:30AM EDT - Add to calendar
Mar 13, 2014
PharMerica Corporation at Barclays Healthcare Conference - Webcast
Feb 28, 2014
Q4 2013 PharMerica Corporation Earnings Conference Call - Webcast
Feb 28, 2014
Q4 2013 PharMerica Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 0.98% 1.08%
Operating margin 3.09% 3.17%
EBITD margin - 6.89%
Return on average assets 2.02% 2.11%
Return on average equity 3.84% 4.18%
Employees 4,700 -
CDP Score - -

Address

1901 CAMPUS PLACE
LOUISVILLE, KY 40299
United States - Map
+1-502-6277000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PharMerica Corporation is an institutional pharmacy services company, which services healthcare facilities and provides management pharmacy services to hospitals. As of December 31, 2011, the Company operated 95 institutional pharmacies in 44 states. The Company operates in two segments: institutional pharmacies and hospital pharmacy management. Institutional pharmacies provide pharmacy services to nursing centers and other healthcare providers, and the hospital pharmacy management business provides management services to substantially all of Kindred Healthcare, Inc.�s hospitals. In January 2014, the Company announced that it has completed the all-cash acquisition of BGS Pharmacy Partners, Inc.

Officers and directors

Geoffrey G. Meyers Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Gregory S. Weishar Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
David W. Froesel Jr. Chief Financial Officer, Executive Vice President, Treasurer
Age: 61
Bio & Compensation  - Reuters
Suresh Vishnubhatla Senior Vice President, Chief Technology Officer
Age: 44
Bio & Compensation  - Reuters
Berard E. Tomassetti Senior Vice President, Chief Accounting Officer
Age: 57
Bio & Compensation  - Reuters
Thomas A. Caneris Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Mark R. Lindemoen Senior Vice President - Sales and Client Services
Age: 46
Bio & Compensation  - Reuters
Robert A. McKay Senior Vice President - Purchasing and Trade Relations
Age: 51
Bio & Compensation  - Reuters
Christopher Schaefer Senior Vice President - Corporate Development
Age: 37
Bio & Compensation  - Reuters
Frank E. Collins Esq. Independent Director
Age: 59
Bio & Compensation  - Reuters